Literature DB >> 7312463

Normal pressure hydrocephalus in the newborn.

A Hill, J J Volpe.   

Abstract

The entity of normal pressure hydrocephalus (NPH) following intraventricular hemorrhage in the newborn has been characterized. Of 87 infants with intraventricular hemorrhage, 20 had early and rapidly progressive hydrocephalus with intracranial hypertension and/or death. In 47 cases there was no increase in ventricular size and in 20 cases there was progressive increase in ventricular size with normal intracranial pressure, ie, NPH. Of these infants with NPH, nine had spontaneous arrest with or without resolution of ventriculomegaly, beginning within 31 days of onset. In 11 cases, after a stable period of NPH lasting 12 to 84 days, there was progressive increase in ventricular size accompanied ultimately by raised intracranial pressure. A relationship between the degree of ventriculomegaly and severity of intraventricular hemorrhage was demonstrated. The data thus define a state of NPH after intraventricular hemorrhage and indicate that approximately half of such cases will not develop progressive hydrocephalus with increased intracranial pressure. If arrest or onset of resolution of ventriculomegaly is not apparent within approximately one month, continued progression and necessity for intervention are to be expected. Serial measurements of intracranial pressure and ventricular size in newborns with posthemorrhagic ventricular dilation allow the diagnosis of NPH and permit early recognition of rapidly progressive ventricular dilation with intracranial hypertension which may follow a stable period of NPH. Such early recognition of this potentially harmful state allows prompt ventricular drainage, thereby preventing brain compression.

Entities:  

Mesh:

Year:  1981        PMID: 7312463

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

1.  Umbilical granulomas: a randomised controlled trial.

Authors:  J Daniels; F Craig; R Wajed; M Meates
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

2.  The influence of head position on the intracranial pressure in preterm infants with posthemorrhagic hydrocephalus.

Authors:  B Urlesberger; W Müller; E Ritschl; F Reiterer
Journal:  Childs Nerv Syst       Date:  1991-04       Impact factor: 1.475

3.  Correlation of ventricular size and head circumference after severe intra-periventricular haemorrhage in preterm infants.

Authors:  W D Müller; B Urlesberger
Journal:  Childs Nerv Syst       Date:  1992-02       Impact factor: 1.475

4.  Diagnosis of brain neuropathology in utero.

Authors:  D H Pretorius; P D Russ; C M Rumack; M L Manco-Johnson
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

5.  Sonography of the premature brain: intracranial hemorrhage and periventricular leukomalacia.

Authors:  E G Grant
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

6.  Cerebrospinal fluid pressure during post haemorrhagic ventricular dilatation in newborn infants.

Authors:  A M Kaiser; A G Whitelaw
Journal:  Arch Dis Child       Date:  1985-10       Impact factor: 3.791

7.  Neurosonography of hydrocephalus in infants.

Authors:  G D Shackelford
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

8.  Timing and evolution of periventricular haemorrhage in infants weighing 1250 g or less at birth.

Authors:  W Szymonowicz; V Y Yu
Journal:  Arch Dis Child       Date:  1984-01       Impact factor: 3.791

9.  The significance of morphological details for developmental outcome in infantile hydrocephalus.

Authors:  R W Oberbauer
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

10.  Posthaemorrhagic ventricular dilatation in the premature infant: natural history and predictors of outcome.

Authors:  B P Murphy; T E Inder; V Rooks; G A Taylor; N J Anderson; N Mogridge; L J Horwood; J J Volpe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.